Your browser doesn't support javascript.
loading
Randomized, double-blind, multi-center, positive parallel control clinical trial of compound Wuzhigan capsules on anemopyretic cold / 中国中药杂志
Zhongguo Zhong Yao Za Zhi ; (24): 531-535, 2014.
Article de Zh | WPRIM | ID: wpr-321391
Bibliothèque responsable: WPRO
ABSTRACT
Compound Wuzhigan capsules is a compound preparation composed of Wuzhigan, Shidagonglao, Gangmei, Shanzhima. A Randomized, double-blind, multi-center, positive parallel control designed to evaluate the clinical efficacy and safety of compound Wuzhigan capsules on anemopyretic cold. One hundred and twenty anemopyretic cold patients were given compound Wuzhigan capsules (test group), 2 capsules one time, three times a day, 119 patients were given compound Wuzhigan tablets (control group) ,4 tablets one time, three times a day; three days of treatment The study showed, the markedly effective rate and total effective rate respectively were 63. 3% and 80% of the test group. For the control group, the markedly effective rate and total effective rate respectively were 72. 5% and 80. 7%. The difference was not statistically significant. Compound Wuzhigan capsules can reduce the dosage, and get better patient compliance.
Sujet(s)
Texte intégral: 1 Indice: WPRIM Sujet Principal: Sécurité / Capsules / Médicaments issus de plantes chinoises / Méthode en double aveugle / Résultat thérapeutique / Rhume banal / Utilisations thérapeutiques / Traitement médicamenteux Type d'étude: Clinical_trials Limites du sujet: Adult / Female / Humans / Male langue: Zh Texte intégral: Zhongguo Zhong Yao Za Zhi Année: 2014 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Sécurité / Capsules / Médicaments issus de plantes chinoises / Méthode en double aveugle / Résultat thérapeutique / Rhume banal / Utilisations thérapeutiques / Traitement médicamenteux Type d'étude: Clinical_trials Limites du sujet: Adult / Female / Humans / Male langue: Zh Texte intégral: Zhongguo Zhong Yao Za Zhi Année: 2014 Type: Article